ASND Ascendis Pharma AS

USD 137.50 -2.81 ( (-2.00%))
Icon

Ascendis Pharma AS (ASND) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 137.50

-2.81 (-2.00%)

USD 8.02B

0.16M

USD 183.14(+33.19%)

USD 133.00 (-3.27%)

Icon

ASND

Ascendis Pharma AS (USD)
COMMON STOCK | NSD
USD 137.50
-2.81 ( (-2.00%))

Ascendis Pharma AS (ASND) Stock Forecast

Show ratings and price targets of :
USD 183.14
(+33.19%)

Based on the Ascendis Pharma AS stock forecast from 13 analysts, the average analyst target price for Ascendis Pharma AS is USD 183.14 over the next 12 months. Ascendis Pharma AS’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ascendis Pharma AS is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Ascendis Pharma AS’s stock price was USD 137.50. Ascendis Pharma AS’s stock price has changed by +0.82% over the past week, +0.87% over the past month and +8.18% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...